CytomX Therapeutics shares rise 10.24% intraday after presenting PROBODY platform and oncology pipeline updates at the JP Morgan Healthcare Conference and announcing partnerships with Bristol Myers Squibb, Amgen, Astellas, Regeneron, and Moderna.
ByAinvest
Friday, Jan 16, 2026 10:26 am ET1min read
CTMX--
CytomX Therapeutics surged 10.24% in intraday trading, with the company presenting updates on its PROBODY platform and oncology pipeline at the 44th JP Morgan Healthcare Conference, including clinical advances for Varseta-M in colorectal cancer and CX-801 in melanoma, alongside announcing partnerships with Bristol Myers Squibb, Amgen, Astellas, Regeneron, and Moderna, and extending its cash runway to Q2 2027.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet